| INTRODUCTION
Approximately 5-20% of prostate cancer (PCA) is due to a strong-tomoderate inherited genetic predisposition. 1 Multiple genes have been associated with inherited PCA including BRCA1, BRCA2, and HOXB13, with data emerging regarding DNA mismatch repair genes also predisposing to PCA. 1, 2 Furthermore, tumor sequencing studies in metastatic PCA are identifying inherited mutations in a broader range of DNA repair genes in up to 20% of patients. [3] [4] [5] Multiple commercial genetic testing (GT) laboratories now offer multigene tests for PCA, including genes with strong evidence of PCA predisposition, genes with lesser degree of evidence for PCA risk, and genes with limited/no data in the context of PCA. 6, 7 Furthermore, NCCN guidelines have expanded GT recommendations for PCA to include testing men with high risk to metastatic disease, or even lower risk/earlier stage disease based upon family history of cancers suggestive of hereditary breast and ovarian cancer or Lynch syndrome. [8] [9] [10] Specifically, multigene testing is included as a consideration for testing by the NCCN PCA treatment guideline (Version 1.2018) including BRCA1/2, ATM, PALB2, and FANCA, to inform options for precision treatment, clinical trials, and active surveillance discussions. 9 Two consensus conferences also addressed GT for PCA-one providing expert guidance on multigene testing based upon familial and personal cancer features and considerations for management and the other focused on GT in the advanced stage setting. 7, 11 Thus, the rapid expansion in guidelines and expert opinion regarding GT for men with PCA will lead to increased multigene testing, necessitating focused efforts to optimize genetic counseling (GC) among males.
Research regarding GT and counseling for PCA among males is limited. Early studies showed that men were generally interested in GT. [12] [13] [14] Interest was primarily higher among men with a documented family history of PCA or those reporting increased levels of worry about a PCA diagnosis. [12] [13] [14] Cancer GC has traditionally been practiced in person, with patients traveling to a health care facility to meet with a trained genetics counselor. 19 The increasing uptake of GT is leading to a higher demand for genetic counselors, with a need to explore alternate GC delivery methods, such as through telephone and telehealth. Alternate service delivery models have been tested and evaluated primarily in the context of GC for breast and ovarian cancers, [20] [21] [22] but little research has been devoted specifically to GT for inherited PCA risk and GC delivery in men.
Genetic Evaluation of Men (GEM) is a prospective multigene testing study for PCA susceptibility in the context of GC. Initial analysis of the GEM study found that 5.5% of 200 males had a genetic mutation identified from multigene testing, and 35% of the cohort had a VUS identified. 6 We surveyed men pre-GT and post-GT regarding knowledge of cancer risk and genetics (CRG) and understanding of their personal genetic test results for insights into the needs of men undergoing germline GT for inherited PCA.
| MATERIALS AND METHODS

| Eligibility criteria
Eligibility criteria for the GEM study have been described in detail previously. 6 6 GEM is approved by the IRB at SKCC and FCCC.
| GC and multigene testing
Participants of GEM undergo pre-and post-test GC employing various counseling delivery methods. be sensitive for identifying inadequate health literacy. 27 Numeracy was assessed using a three-question survey used in prior studies and was scored as the total number of correct responses. 28 Post-test survey retested on knowledge of PCA risk and genetics, health literacy, numeracy, and included an additional question addressing understanding of personal genetic test results: "I was found to carry a genetic mutation (a genetic change)" (yes, no, do not know).
| Statistical methods
Participants completing both the pre-and post-test surveys were included in analyses. Participant demographic characteristics as well as family history of cancer were summarized with counts and percentages overall and within study site. Differences in subject characteristics between sites were assessed using Fisher's exact tests and t-tests where appropriate. Associations between both pre-test knowledge and change in knowledge were assessed using linear regression. Table S1 ). The demographic characteristics of this cohort of 109 males is shown in Table 1 . The mean age of the cohort was 62.5 years (SD 8.1 years). White males comprised 80.7% of the cohort, and 86.2% of the cohort was married.
Education status was at least some college or higher for 83.5% of the cohort. There was a significant difference in education level and PCA status by site (Supplementary Tables S2 and S3 ). Greater percentage of participants at Site 1 had some college or less education while at Site 2 participants had college or higher education (P = 0.025) (Supplementary Table S2 ). PCA status was higher among participants at Site 2 compared to Site 1 (P < 0.001) (Supplementary Table S3 ).
Personal and family history characteristics are shown in Table 2 The mean change in overall knowledge score from pre-to post-test was 0.8 (SD 2.6, P = 0.001). Table 3 displays results of univariable analysis of factors associated with knowledge of CRG from the pretest survey. Higher pre-test knowledge of CRG was associated with meeting criteria for a HCS (P = 0.006) and higher numeracy (P = 0.025).
On multivariable analysis, family history meeting criteria for a HCS remained significantly predictive of higher pre-test knowledge (P = 0.040) ( Table 4) . No factors were associated with change in knowledge from pre-to post-test timepoints.
| Understanding of personal genetic test results
Of 101 men who responded definitively regarding understanding of personal genetic test results (6 responded "don't know" and 2 provided no answer), 88 men responded correctly regarding their genetic test result and 13 responded incorrectly, that is, answering that they carry a genetic mutation when their result showed no mutation (McNemar's P < 0.001). Of these 13 men, 12 men reported they had a mutation when their test report revealed > = 1 VUS, and one male reported having a mutation when his result was negative. Overall, having a VUS genetic test result was significantly associated with incorrectly reporting genetic test results (P < 0.001). Furthermore, undergoing GC utilizing pre-test video and post-test phone disclosure was also associated with lack of understanding genetic test results (P = 0.015), which likely pertained to the participants receiving VUS results. 
| DISCUSSION
GT for inherited PCA is expected to increase with greater testing capability and expansion of guidelines. [6] [7] [8] [9] [10] [11] Recent updates to the Since GT for PCA is a relatively new field, focused efforts are needed to optimize the counseling experience for men undergoing GT for inherited PCA.
Our results show that men with a personal/family history of HCS telehealth. This is particularly relevant for men who receive VUS findings, as these men had less understanding of their results. Since GC expertise is in demand, employing alternate delivery methods such as telephone, video, and telehealth will need to be thoughtfully utilized with attention to the needs and understanding of men undergoing GT for inherited PCA. It has been suggested that patients may be most satisfied when they are allowed to choose the method of their GC, 31 although this an area ripe for future research.
Personalized medicine and pre-symptomatic GT has received an abundance of attention from the media and healthcare providers yet understanding the impact of these tests on patient understanding and behaviors has been slow to follow. This is particularly of concern for GT and counseling for men, as studies in this patient population have not been as extensively performed. The public's perception of the accuracy and utility of GT is frequently overestimated, 32 and was seen to some extent in the results of our study. Education delivered by a healthcare professional has been shown to increase a patient's knowledge about their test results and their feelings of personal control, while decreasing levels of anxiety and cancer fatalism.
33-35
Our results support developing and evaluating theoretically-driven, structured education protocols for PCA GT that are also culturally appropriate and targeted to the specific psychological needs of the population. 36 There are some limitations of this study that should be considered.
The overall sample size is fairly small, and larger studies are needed to models of counseling delivery for optimal GC and testing experience for men undergoing genetic evaluation for inherited PCA.
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